ACOR News and Press, Acorda Therapeutics Inc. From 10/22/19

“Do Tell” Your Doctor Tool was adapted from a clinically validated questionnaire developed by Duke University, with input from the Parkinson’s community Acorda Therapeutics, Inc. (NASDAQ: ACOR) today announced the launch of the “Do Tell” Your Doctor...

Acorda Therapeutics, Inc. (NASDAQ:ACOR) will host a conference call and webcast to report its third quarter 2019 update and financial results on Monday, November 4 at 4:30 p.m. ET. To participate in the conference call, please dial (833) 236-2756 (domestic) or (647) 689-4181 (internationa...

Acorda Therapeutics, Inc. (NASDAQ: ACOR) announced that Ron Cohen, M.D., Acorda’s President and Chief Executive Officer, will present at the 2019 Cantor Global Healthcare Conference on Friday, October 4 at 11:15AM ET. A live audio webcast of the presentation can be accessed under ...

Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that it will present data at the International Congress of Parkinson’s Disease and Movement Disorders, taking place September 22-26, 2019 in Nice, France. The data include two posters, which will be presented on Tuesday, Sept...

Mitsubishi Tanabe Pharma America ( OTCPK:MTZPY -1.5% ) initiates a Phase 3 clinical trial, BouNDless , evaluating continuous subcutaneously administered carbidopa/levodopa (ND0612) compared to the oral formulation in Parkinson's disease (PD) patients. More news on: Mitsubishi Tanabe P...

Amarin (NASDAQ: AMRN ) initiated with Outperform rating and $26 (82% upside) price target at SVB Leerink. More news on: Amarin Corporation plc, Tenet Healthcare Corporation, Bristol-Myers Squibb Company, Healthcare stocks news, Stocks on the move, , Read more ...

Acorda Therapeutics ( ACOR ) recently reported a huge earnings beat in both earnings per share “EPS” and revenue. The company beat in Non-GAAP EPS of -$0.55 (beats by $0.51) and a GAAP EPS of -$0.58 (beats by $0.68), with revenue coming in at $50.05M which was a $21.22M bea...

Gainers: ABMD   +5.7% . OBLN   +5.6% . ACOR   +5.1% . ERIC   +4.2% . More news on: Abiomed, Inc., Obalon Therapeutics, Inc., Acorda Therapeutics, Inc., Stocks on the move, , News on ETFs Read more ...

The following slide deck was published by Acorda Therapeutics, Inc. in conjunction with their 2019 Q2 earnings Read more ...

Gainers:  Aphria (NYSE: APHA ) +36% . Natural Grocers by Vitamin Cottage (NYSE: NGVC ) +33% . BlackLine (NASDAQ: BL ) +29% . Regional Health Properties (NYSEMKT: RHE ) +22% . Griffon Corporation (NYSE: GFF ) +20% . PC Connection (NASDAQ: CNXN ) +19% . Pinterest (NYSE: PINS ) +1...